Sutro Biopharma (STRO) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Sutro Biopharma Revenue Highlights


Latest Revenue (Y)

$153.73M

Latest Revenue (Q)

$13.01M

Main Segment (Y)

Collaboration Revenue

Main Geography (Y)

Collaboration Revenue

Sutro Biopharma Revenue by Period


Sutro Biopharma Revenue by Year

DateRevenueChange
2023-12-31$153.73M126.84%
2022-12-31$67.77M9.52%
2021-12-31$61.88M44.84%
2020-12-31$42.72M-0.03%
2019-12-31$42.74M11.24%
2018-12-31$38.42M-25.75%
2017-12-31$51.74M-13.38%
2016-12-31$59.73M-

Sutro Biopharma generated $153.73M in revenue during NA 2023, up 126.84% compared to the previous quarter, and up 400.14% compared to the same period a year ago.

Sutro Biopharma Revenue by Quarter

DateRevenueChange
2024-03-31$13.01M-88.56%
2023-12-31$113.72M571.95%
2023-09-30$16.92M62.54%
2023-06-30$10.41M-17.85%
2023-03-31$12.67M46.83%
2022-12-31$8.63M-65.67%
2022-09-30$25.15M-10.50%
2022-06-30$28.10M376.45%
2022-03-31$5.90M-44.65%
2021-12-31$10.65M25.09%
2021-09-30$8.52M-69.64%
2021-06-30$28.05M91.33%
2021-03-31$14.66M77.10%
2020-12-31$8.28M-53.55%
2020-09-30$17.82M88.22%
2020-06-30$9.47M32.40%
2020-03-31$7.15M-36.74%
2019-12-31$11.30M-7.92%
2019-09-30$12.28M16.65%
2019-06-30$10.53M21.97%
2019-03-31$8.63M-54.79%
2018-12-31$19.09M143.57%
2018-09-30$7.84M37.38%
2018-06-30$5.70M-1.54%
2018-03-31$5.79M43.39%
2017-12-31$4.04M-76.91%
2017-09-30$17.50M15.88%
2017-06-30$15.10M-
2017-03-31$15.10M-

Sutro Biopharma generated $13.01M in revenue during Q1 2024, up -88.56% compared to the previous quarter, and up 150.70% compared to the same period a year ago.

Sutro Biopharma Revenue Breakdown


Sutro Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 18
Other Revenue$5.42M
Collaboration Revenue$13.54M

Sutro Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 18: Collaboration Revenue (71.40%), and Other Revenue (28.60%).

Quarterly Revenue by Product

Product/ServiceDec 18Sep 18
Other Revenue$654.00K$912.00K
Collaboration Revenue$18.43M-

Sutro Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Dec 18: Collaboration Revenue (96.57%), and Other Revenue (3.43%).

Sutro Biopharma Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 18
Collaboration Revenue$13.54M
Other Revenue$5.42M

Sutro Biopharma's latest annual revenue breakdown by geography, as of Dec 18: Collaboration Revenue (71.40%), and Other Revenue (28.60%).

Quarterly Revenue by Country

CountryDec 18Sep 18
Other Revenue$654.00K$912.00K
Collaboration Revenue$18.43M-

Sutro Biopharma's latest quarterly revenue breakdown by geography, as of Dec 18: Collaboration Revenue (96.57%), and Other Revenue (3.43%).

Sutro Biopharma Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
STROSutro Biopharma$153.73M$13.01M
MRUSMerus$43.95M$11.77M
IDYAIDEAYA Biosciences$23.39M-
ANABAnaptysBio$17.16M$10.97M
MGTXMeiraGTx$14.02M$282.00K
CNTACentessa Pharmaceuticals$6.88M-
FIXXQ32 Bio$1.16M-
KROSKeros Therapeutics$151.00K$83.00K
OPTOpthea$108.41K$61.27K
PCVXVaxcyte--
AVTEAerovate Therapeutics--
REPLReplimune Group--
ELYMEliem Therapeutics--
SNDXSyndax Pharmaceuticals-$3.50M
MLYSMineralys Therapeutics--
LRMRLarimar Therapeutics--
PRDSPardes Biosciences--
HLVXHilleVax--
GNTAGenenta Science S.p.A.--

STRO Revenue FAQ


Sutro Biopharma's yearly revenue for 2023 was $153.73M, representing an increase of 126.84% compared to 2022. The company's yearly revenue for 2022 was $67.77M, representing an increase of 9.52% compared to 2021. STRO's yearly revenue for 2021 was $61.88M, representing an increase of 44.84% compared to 2020.

Sutro Biopharma's quarterly revenue for Q1 2024 was $13.01M, a -88.56% decrease from the previous quarter (Q4 2023), and a 2.64% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $113.72M, a 571.95% increase from the previous quarter (Q3 2023), and a 1217.44% increase year-over-year (Q4 2022). STRO's quarterly revenue for Q3 2023 was $16.92M, a 62.54% increase from the previous quarter (Q2 2023), and a -32.70% decrease year-over-year (Q3 2022).

Sutro Biopharma's revenue growth rate for the last 3 years (2021-2023) was 148.43%, and for the last 5 years (2019-2023) was 259.72%.

Sutro Biopharma's revenue streams in c 18 are Other Revenue, and Collaboration Revenue. Other Revenue generated $5.42M in revenue, accounting 28.60% of the company's total revenue Collaboration Revenue generated $13.54M in revenue, accounting 71.40% of the company's total revenue

For the fiscal year ending Dec 18, the largest source of revenue of Sutro Biopharma was Collaboration Revenue. This segment made a revenue of $13.54M, representing 71.40% of the company's total revenue.